Final answer:
In this case, the student with a history of type 2 diabetes (DMT2) and recurrent pancreatitis would benefit from starting liraglutide (Victoza), a glucagon-like peptide-1 (GLP-1) receptor agonist.
Step-by-step explanation:
In this case, the student has a history of type 2 diabetes (DMT2) with a high A1C level of 9. They also have recurrent pancreatitis and are intolerant to metformin. Since the student does not want to start insulin, there are several other medication options available for managing diabetes.
Out of the given options, it would be appropriate to start liraglutide (Victoza), which is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 receptor agonists work by increasing insulin secretion, reducing glucagon secretion, and slowing gastric emptying, thereby improving blood sugar control. This medication is suitable for patients with a history of pancreatitis and can also help with weight loss.
Therefore, the correct choice in this case would be to start liraglutide (Victoza).